These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9402325)

  • 1. P-glycoprotein expression in de novo acute myeloid leukemia.
    Del Poeta G; Venditti A; Aronica G; Stasi R; Cox MC; Buccisano F; Bruno A; Tamburini A; Suppo G; Simone MD; Epiceno AM; Del Moro B; Masi M; Papa G; Amadori S
    Leuk Lymphoma; 1997 Oct; 27(3-4):257-74. PubMed ID: 9402325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Aronica G; Venditti A; Cox MC; Bruno A; Buccisano F; Masi M; Tribalto M; Amadori S; Papa G
    Blood; 1996 Mar; 87(5):1997-2004. PubMed ID: 8634450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
    Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
    Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.
    Ludescher C; Eisterer W; Hilbe W; Gotwald M; Hofmann J; Zabernigg A; Cianfriglia M; Thaler J
    Leukemia; 1995 Feb; 9(2):350-6. PubMed ID: 7869774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
    Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
    Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein (P-170) and CD34 expression in adult acute myeloid leukemia (AML).
    Lamy T; Goasguen JE; Mordelet E; Grulois I; Dauriac C; Drenou B; Chaperon J; Fauchet R; le Prise PY
    Leukemia; 1994 Nov; 8(11):1879-83. PubMed ID: 7526090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.
    Goasguen JE; Dossot JM; Fardel O; Le Mee F; Le Gall E; Leblay R; LePrise PY; Chaperon J; Fauchet R
    Blood; 1993 May; 81(9):2394-8. PubMed ID: 8097634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein expression and prognostic value in acute myeloid leukemia.
    Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA
    Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia.
    Poulain S; Lepelley P; Cambier N; Cosson A; Fenaux P; Wattel E
    Adv Exp Med Biol; 1999; 457():57-63. PubMed ID: 10500780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in acute leukemia: a comparison of different diagnostic methods.
    Pall G; Spitaler M; Hofmann J; Thaler J; Ludescher C
    Leukemia; 1997 Jul; 11(7):1067-72. PubMed ID: 9204993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD7 expression in acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
    Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay.
    Lamy T; Drenou B; Grulois I; Fardel O; Jacquelinet C; Goasguen J; Dauriac C; Amiot L; Bernard M; Fauchet R
    Leukemia; 1995 Sep; 9(9):1549-55. PubMed ID: 7658724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-Kit and functional drug efflux are correlated in de novo acute myeloid leukaemia.
    Sincock PM; Ashman LK
    Leukemia; 1997 Nov; 11(11):1850-7. PubMed ID: 9369417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein and multidrug resistance-associated protein-1 expression in acute myeloid leukemia: Biological and prognosis implications.
    da Silveira Júnior LS; Soares VL; Jardim da Silva AS; Gil EA; Pereira de Araújo MDG; Merces Gonçalves CA; Paiva AS; Moura de Oliveira TM; Oliveira GHM; Kramer Cavacanti E Silva DG; de Araújo Moura Lemos TM; Moretti Rebecchi IM; de Farias Sales VS; Luchessi AD; Cavalcanti Júnior GB
    Int J Lab Hematol; 2020 Oct; 42(5):594-603. PubMed ID: 32452631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression.
    Legrand O; Perrot JY; Simonin G; Baudard M; Cadiou M; Blanc C; Ramond S; Viguié F; Marie JP; Zittoun R
    Br J Haematol; 1998 Jan; 100(1):147-55. PubMed ID: 9450804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia.
    List AF; Spier CS; Grogan TM; Johnson C; Roe DJ; Greer JP; Wolff SN; Broxterman HJ; Scheffer GL; Scheper RJ; Dalton WS
    Blood; 1996 Mar; 87(6):2464-9. PubMed ID: 8630412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia.
    Del Principe MI; Del Poeta G; Maurillo L; Buccisano F; Venditti A; Tamburini A; Bruno A; Cox MC; Suppo G; Tendas A; Giannì L; Postorino M; Masi M; Del Principe D; Amadori S
    Br J Haematol; 2003 Jun; 121(5):730-8. PubMed ID: 12780787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome.
    Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F
    Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein expression in acute myeloblastic leukemia analyzed by immunocytochemistry and flow cytometry.
    Longo R; Bensi L; Vecchi A; Messora C; Sacchi S
    Leuk Lymphoma; 1995 Mar; 17(1-2):121-5. PubMed ID: 7773148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of P glycoprotein expression by immunocytochemistry and flow cytometry coupled with functional efflux analysis: application to acute myeloid leukemia].
    Poulain S; Lepelley P; Cambier N; Wattel E; Fenaux P; Cosson A
    Ann Biol Clin (Paris); 1999; 57(5):595-600. PubMed ID: 10518062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.